Completeness of revascularization in multivessel coronary artery disease
- PMID: 28066641
- PMCID: PMC5179393
- DOI: 10.21037/jtd.2016.11.42
Completeness of revascularization in multivessel coronary artery disease
Conflict of interest statement
Dr. Brilakis—research support from the department of Veterans Affairs (PI of the Drug Eluting Stents in Saphenous Vein Graft Angioplasty-DIVA trial and Merit grant-I01-CX000787-01) and from the National Institutes of Health (1R01HL102442-01A1); consulting/honoraria from St Jude Medical, Boston Scientific, Asahi, Janssen, Sanofi, Abbott Vascular, Somahlution, Elsevier, and Terumo; research support from Guerbet; spouse is an employee of Medtronic. The other authors have nothing to disclose.
Figures
Comment on
-
Complete versus incomplete revascularization in patients with multivessel coronary artery disease treated with drug-eluting stents.Am Heart J. 2016 Sep;179:157-65. doi: 10.1016/j.ahj.2016.06.020. Epub 2016 Jul 7. Am Heart J. 2016. PMID: 27595691
References
-
- Buda AJ, Macdonald IL, Anderson MJ, et al. Long-term results following coronary bypass operation. Importance of preoperative actors and complete revascularization. J Thorac Cardiovasc Surg 1981;82:383-90. - PubMed
Publication types
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources